Iterum Therapeutics Receives FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections Read more
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer’s Disease and Neuroscience Pipeline Read more
Astellas Provides Update on Marketing Authorization Application for Avacincaptad Pegol (ACP) in the European Union Read more
TreeFrog Therapeutics Enters Into Pioneering Research Collaboration in Immuno-Oncology With the University of Pittsburgh Read more
European Commission Approves DARZALEX (daratumumab)-SC Quadruplet Regimen for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Read more
Lilly’s Kisunla Gains Marketing Authorization in Great Britain for Alzheimer’s Treatment in Select Adult Patients Read more